GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue
Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.